Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT05060471What this trial is testingPD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA PatientsWho this might be right forAnal Canal CancerAnal Squamous Cell CarcinomaAnal Cancer+3 more Sun Yat-sen University 25
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00025090What this trial is testingRadiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal CancerWho this might be right forAnal Cancer University College London (UCL) Cancer Institute 600
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT04719988What this trial is testingAnti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.Who this might be right forSquamous Cell Carcinoma of the Anus Stage III Centre Hospitalier Universitaire de Besancon 55
Large-scale testing (Phase 3)Study completedNCT00003652What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerWho this might be right forAnal Cancer UNICANCER 350
Large-scale testing (Phase 3)UnknownNCT05374252What this trial is testingChemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma PatientsWho this might be right forAnal Canal Cancer Stage IIIAnal Squamous Cell CarcinomaAnal Canal Cancer+1 more Sixth Affiliated Hospital, Sun Yat-sen University 102
Testing effectiveness (Phase 2)Study completedNCT00316888What this trial is testingCetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal CancerWho this might be right forAnal Cancer ECOG-ACRIN Cancer Research Group 63
Large-scale testing (Phase 3)Looking for participantsNCT07692152What this trial is testingSintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell CarcinomaWho this might be right forAnal Squamous Cell Carcinoma, Limited-stage Cancer Institute and Hospital, Chinese Academy of Medical Sciences 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT04929028What this trial is testingTherapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerWho this might be right forAIDS-Related Anal CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell Carcinoma+7 more National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT00003596What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerWho this might be right forAnal Cancer Radiation Therapy Oncology Group 682
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)Ended earlyNCT00068744What this trial is testingRadiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal CancerWho this might be right forAnal Cancer European Organisation for Research and Treatment of Cancer - EORTC 88
Large-scale testing (Phase 3)UnknownNCT02526953What this trial is testingEfficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma PatientsWho this might be right forAnus NeoplasmsCarcinoma, Squamous CellAnus Diseases+3 more Blokhin's Russian Cancer Research Center 314
Testing effectiveness (Phase 2)Study completedNCT00423293What this trial is testingIntensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal CancerWho this might be right forAnal Cancer Radiation Therapy Oncology Group 63
Testing effectiveness (Phase 2)UnknownNCT02560298What this trial is testingCisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal CancerWho this might be right forAnal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Squamous Cell Carcinoma+4 more ECOG-ACRIN Cancer Research Group 91
Large-scale testing (Phase 3)Active Not RecruitingNCT03233711What this trial is testingNivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal CancerWho this might be right forAnal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell Carcinoma+2 more National Cancer Institute (NCI) 344
Not applicableStudy completedNCT05130073What this trial is testing4-Point Therapy Response Score With PET/CT for Anal Squamous Cell CancerWho this might be right forAnal Squamous Cell CarcinomaStage 0 Anal Cancer AJCC v8Stage I Anal Cancer AJCC v8+7 more M.D. Anderson Cancer Center 41